NORMALISIERUNG EINER TUMORMUTATIONSLAST

Patent europeic · EP3704268 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3704268
Numer da la dumonda
EP18872946
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
02-11-2018
Publitgà
09-09-2020
Concedì
22-01-2025
La protecziun finescha il pli tard
01-11-2038
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
G16B 20/00 (2019.01)
C12Q 1/6827 (2018.01)
C12Q 1/6886 (2018.01)
Prioritad
US 201762581563 P 03.11.2017
Dumonda PCT
PCT/US2018/059068 02.11.2018
Publicaziun PCT
WO2019/090156 09.05.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-12-2025

    Midada

    Published in Swissreg on 24.12.2025

  2. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  3. 29-10-2025

    Midada

    Published in Swissreg on 29.10.2025

  4. 28-01-2025

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 28.01.2025

  5. 22-01-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.01.2025

Partidas

Possessur

Guardant Health, Inc.

3100 Hanover Street, Palo Alto, CA 94304, US

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

CHUDOVA, Darya

Redwood City, CA 94063, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.